In people who are hypertensive and have microalbuminuria, however, there is relatively strong evidence to suggest that ACE inhibition slows progression of diabetic nephropathy in people with type 1 diabetes and microalbuminuria [57]. Here, ACE is linked to diabetic kidney disease.